SCHEMBL1503453

SCHEMBL1503453

Cc1c(C(C)[SiH3])ccc(N(C)C)c1C

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10933423 0.80 CHEK1 (0.30)
SCHEMBL1503457 0.69 CHEK1 (0.35)
SCHEMBL392464 0.67 GAA (0.33) ALDH1A1TSHR
SCHEMBL21173492 0.67 MAPT (0.33) ALDH1A1TSHR
SCHEMBL10438997 0.64 CHEK1 (0.50) ALDH1A1TSHR
SCHEMBL8476289 0.64 CHEK1 (0.31)
SCHEMBL20285962 0.64 TRPA1 (0.47) ALDH1A1TSHR
SCHEMBL10304860 0.64 GABRA1 (0.43) ALDH1A1TSHR
SCHEMBL20285948 0.64 TRPA1 (0.52) ALDH1A1TSHR
Hydrochloric Acid SCHEMBL28477496 0.62 GAA (0.42) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10941301-B2 Surface treatment method, surface treatment agent, and method for forming film region-selectively on substrate TOKYO OHKA KOGYO CO., LTD. (JP) 2021-03-09 US disclosed
US-20190203054-A1 SURFACE TREATMENT METHOD, SURFACE TREATMENT AGENT, AND METHOD FOR FORMING FILM REGION-SELECTIVELY ON SUBSTRATE TOKYO OHKA KOGYO CO., LTD. (JP) 2019-07-04 US disclosed
US-10093815-B2 Surface treatment agent and surface treatment method TOKYO OHKA KOGYO CO., LTD. (JP) 2018-10-09 US disclosed
US-20170088722-A1 SURFACE TREATMENT AGENT AND SURFACE TREATMENT METHOD TOKYO OHKA KOGYO CO., LTD. (JP) 2017-03-30 US disclosed
US-20110054184-A1 SURFACE TREATMENT AGENT AND SURFACE TREATMENT METHOD TOKYO OHKA KOGYO CO., LTD. (JP) 2011-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110054184-A1 SURFACE TREATMENT AGENT AND SURFACE TREATMENT METHOD ITGA2, ITGA1, ITGAL ALDH1A1 2552/4885TSHR 2077/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.